article thumbnail

Cancer-associated thoracic aorta arterial thrombosis: case report and review of the literature

Frontiers in Cardiovascular Medicine

BackgroundArterial thrombosis is an uncommon complication in cancer patients, often overshadowed by venous thromboembolic events. LMWH proved effective in resolving the thrombus, underscoring its role in managing such complications.

article thumbnail

API-CAT: Extended Anticoagulant Therapy With Reduced-Dose Apixaban Noninferior to Full-Dose in Patients With Active Cancer and VTE

American College of Cardiology

Extended anticoagulant therapy with a reduced-dose of apixaban was noninferior to extended therapy with a full-dose of apixaban in preventing recurrent venous thromboembolism (VTE) in patients with active cancer and proximal deep-vein thrombosis or pulmonary embolism, based on findings from the API-CAT trial presented at ACC.25

Cancer 70
article thumbnail

Anticoagulation Management of Distal Deep Vein Thrombosis in Cancer Patients

American College of Cardiology

Active cancer is a strong risk factor for venous thromboembolism (VTE) events and recurrent events following discontinuation of anticoagulation therapy, and cancer patients are also at a heightened risk for bleeding complications related to anticoagulation treatment.

Cancer 62
article thumbnail

Rivaroxaban versus low molecular weight heparin for managing lower extremity deep vein thrombosis following thoracoscopic lung cancer surgery: a randomized controlled trial

Journal of Cardiothoracic Surgery

To assess the effectiveness and safety profiles of rivaroxaban compared to low molecular weight heparin (LMWH) in managing lower extremity deep vein thrombosis (DVT) subsequent to thoracoscopic lung cancer sur.

article thumbnail

Application of IMB model in preventing venous thromboembolism in elderly lung cancer patients

Frontiers in Cardiovascular Medicine

Objective This study aims to explore the effects of the Information-Motivation-Behavioral (IMB) Skills Model on the prevention of Venous Thromboembolism (VTE) in elderly lung cancer patients. After three months of intervention, the hospital satisfaction and VTE incidence rates in both groups were investigated and compared.

Cancer 49
article thumbnail

Abstract WMP59: Prognosis After Cerebral Venous Thrombosis: Long-Term Readmission Patterns in a Canadian Population-Based Cohort

Stroke Journal

Background:Information on long-term care utilization patterns following the acute care period of cerebral venous thrombosis (CVT) is limited. Cancer-related CVT was associated with a higher rate of readmission (p<0.0001) and traumatic CVT was associated with a lower rate (p=0.005). years (SD 19). years (95% CI 1.4-2.4),

article thumbnail

Study Demonstrates Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age, Bleeding Risk

DAIC

Abelacimab is currently in Phase 3 development with the lead indication for the prevention of stroke and systemic embolism in patients with atrial fibrillation (LILAC-TIMI 76), in addition to two studies in patients with cancer-associated thrombosis (ASTER and MAGNOLIA). Data from these trials are expected in the second half of 2026.